Nashville Oncology Associates offers Patients Opportunity to Participate in Phase 1/2 Clinical Trial, CHAMP-1, for the Treatment of Advanced Solid Tumors or Diffuse Large B-cell Lymphoma (DLBCL)
May 22, 2023
Nashville Oncology Associates is excited to announce our status as a study location in the Phase 1/2 clinical trial, CHAMP-1. The trial is an open-label, multi-center study for patients with advanced solid tumors or diffuse large B-cell lymphoma (DLBCL). The…
Read Full